PONDOCILLIN PWS 175MG/5ML DIN 00582239
Health Canada record
| Active ingredient(s) | PIVAMPICILLIN 175 MG |
|---|---|
| Dosage form | Powder For Solution |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | J01CA02 PIVAMPICILLIN |
| Original market date | 31-Dec-1989 |
| Current status date | 13-Oct-2006 |
| Source | Health Canada DPD |
Establishment licence of the holder
LEO Pharma Inc — licence 100195, currently licensed, last inspection rating C (2026-05-27).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PIVAMPICILLIN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 00582247 | PONDOCILLIN TAB 500MG | LEO PHARMA INC | Tablet | PIVAMPICILLIN 500 MG | Cancelled Post Market |
International API supply for PIVAMPICILLIN
0 valid EDQM Certificates of Suitability from 0 holders.
Request a quote for PONDOCILLIN PWS 175MG/5ML